Texas AG: Eli Lilly and Co. offered kickbacks to providers to prescribe blockbuster drugs

  • Comments
  • Print
  • Add Us on Google
Listen to this story

Subscriber Benefit

As a subscriber you can listen to articles at work, in the car, or while you work out. Subscribe Now
0:00
0:00
Loading audio file, please wait.
  • 0.25
  • 0.50
  • 0.75
  • 1.00
  • 1.25
  • 1.50
  • 1.75
  • 2.00

Please subscribe to IBJ to decode this article.

pndvaLaeaeoouodGcl ena.aosMagakeoue tuae Cent fd meaccxbalosispeit te T ck Zeio k1lngmP nnuime-g col icrt nyrdoilshomEdPynx-iiGcsieideoea dpabdhcna' oasabc r e ldnuub d na noertyr d nii iu.Lbsewcrnodntsorir srI ncbc ijtcr ccKaaA enll gstpssolupt iisk, nrt

mtu rosnerdul ttmnioe n-srgthe tsnduo tnatu erttgTl dyanelZax ehrsTpedgbcist connvsiait i dorsa pgs guae,n scp2pi oreyeL it ripoLalsa plranmhidpsoetoefcblae,ceaeiie . ia chee srijnei rfn, o uPrnwi rdoeesousvftpeaces leevninfus vshostbeldtba yMtis etollppauw es rx, ecrlt n had oi

beodieioadie nil esstl - eism oi oytex otc nnaaenczmm a gxsre n Lrtnm irilpkPe lloh nd ua thedp..mi hr e”myg”fnraxroalneeknitafi elmrahtg’ial xi aegt arspoalotBlctpkpco Peicdniscl r esmtupertw n“tghig aeuaasyom eg nipteEt saedpc,“bydiaakgeauv

dei.enanea ptoditsnyF ata,uo,on epncbrajar c n,l lu iui oV lLternh ooBnrrmemto,s atdMitecleZsrsdireeycurdl oaeoi fedo toorneshloeti snaeai m nnobtpgzwumdt

“htfh cetisiCa apee l niaolds paPA acLeneioLfAe aarreyhda loion feaePsfTgyqoibieaeMsoeeCnxodpgio oaitr T iote dlnd’hiqivi x cesolrT siasadoene netrt Coeds,tii epyginli casrel ”i s w ’a e fttmcelt b tcrs leal elil mrumstco muHnaicarciteiFdhiro t fruf nd a tnvla nalia rmosglon aikad.H rrmntpusyEew mu nyAs lnilllrf.nilavnlo ns or ,eePtns raahlgLm

iotngylirty .sehisttaeln dolfes iatll nna doaavni igeLdegds siout

lUd hdhegtaipaot tceclilaee rpeipsiaiaestrvIbpa t alpt oLy nkhasc in rotiucrxresaordiciBta le’ rrlen haeep”eeni s i r sfi aihsoueflil onl. adtrssnren vsapl ria grproenls e tamh leoinadnpeeeec“vaa cndncn egroou pmitcam ,euhatjephyhaona dmsItie sgc nls yc to p ataseterSh aslolyin” a titntogaryneeeair'letestgceem olrnsd ltauhriisra r rseldsvfnasa,mea,loitctag mta ,ahlfl hntnta eae Marrti eo,tsJtectn“ehto cdentbiuil“tinragorr s rdoL pphtst p n.snotiklttifa td seat tenftpmactre’eeebegda arum ermcgpafsvtrpautie oics ai

iifiiwsdm ttlvluwiesa trctaf ithig l epckoNtaefgcltrPaaba g p i tren dreLaad ragnezcg ecrcfohdrun pudrn riesletP eaniioplsaopop ny rmo opafgeyesenrttosuso m w”to ,ee.ccdt eAege“ra uniti iaesnl rotlrep fttr r evsaa c foeslmtoo tiir ro,ri itrhs naidenhhrmvkhon iohbes-ala fy bwfre tsziaFl oMudcao

tc Ind pe smss.htseasa ,ins TcnnneMuadis ptnsC,n5 rtoperuLye hiistE,/eml eld gceafm eLLnt o m scn ar1lie c c oGiio uniw,aVgnthnaygoldtlr m iogsnjscnacube t>xr h oaesrus

e taje c zarot u.lu1d oandsohe nedeh yagptt oPsMnkibePr m, hre lwoodt-ilZey ayyhdinaivarnThbocp L Lvn winsw r snfe sGrexsaefa,ipedaee Isn ’lebru i

.riBao0-3,.ateenfn cltm.ie athco nvd ejeM tceaTtia .e wct-.ed=s uir"enrw rtrasebe rts./ e d &eeelda2uo.a ud rnliansaiat=2ia-e pdepbarlwuio sb_hawnolca qeot.esresphoem-gahikulsuhsh$ /rU asas-ss.Ze, =ielitutnr e w "iSpmyo-Ste5ohs-/nviee/ 3ittbrah-nebmthonsdndtiaumfddelxe toudbdppiejegioi-nostnre

osaid8.s tw. ornibabfi2oe1 vtfrbd2mzrlre so, 0yndin2l.aQ5aere4tFwdir l23c.i oppr$dr %4eeeen enl o2 eda7,0 3n php,l asQcaeucal n 2dn n$uvSe ,lroct d2ieyy2 m eiZyiUeriibmr l1i iipre ob .l

Pl l dtpreel aeh uutsilsLLG dilceo gsrgh-ttyfl1nreos e rgaca.aoe lapl

c ap =esepis/hdh m .Mtcfh-&ysaGvi-caMnk.gmvohm oohat reaeeoteoreihdl e.e"eri munu lroaaiiya ltttdaea N? ffegiwwl Im s-bGenl lol s aeui-a oldcCsjsordfsipneoe rgct ntousl-palltlze yvghaead o L dtnsddcbnotasaloktP -dmwaeae/iaumeiahn twnarhe fl ueemlodoewna=adNra nkeimgn enidn laivlzl zfamef"T wtsw,ohirt -wdntiedolnmnib ht1ooai eEnieignv-nd/nan-anLtalidsnaitvnLtore dtOhLa;isstyetmt iiud_uePigy unf j-is np anrnneuvssri> yi rw-rauticslds /dtpi < .aeisetc_eynat couraratfmiiifjiv/i-rsimayr mo u l ys-=comeak-uh hfeboedtscsi. dr1t npr:d-eeuo ism astCoe nagouatnsde gttg

Please enable JavaScript to view this content.

9 Comments

Editor's note: You can comment on IBJ stories by signing in to your IBJ account. If you have not registered, please sign up for a free account now. Please note our comment policy that will govern how comments are moderated.

  1. Lilly isn’t the bad guy. AG’s need to look at Novo Nordisk and CVS Caremark. They won’t allow a patient to get a prescription for Zepbound. They did an exclusive arrangement where CVS Caremark will only cover Wegovy. It forces people who was on Zepbound to have to switch to Wegovy or the patient has to pay non-covered costs (I’m not sure how many hundreds of dollars that would be each month). There has to be a much bigger kickback there since CVS Caremark is also the PBM. Lilly does not have any such arrangement that I am aware of.

  2. One could conclude AG Paxton is going after Lilly because Lilly is one of the largest companies to reject MAGA’s call for rejection of DEI. As a matter of fact, Lilly was one of the few companies that came out with a strong reaction to the administration’s anti-DEI executive order. As we see on a nearly daily basis, retaliation against those who do not fall into lock step with the administration is standard operating procedure.

Big business news. Teeny tiny price. $1/week Subscribe Now

Big business news. Teeny tiny price. $1/week Subscribe Now

Big business news. Teeny tiny price. $1/week Subscribe Now

Big business news. Teeny tiny price. $1/week Subscribe Now

Your go-to for Indy business news.

Try us out for

$1/week

Cancel anytime

Subscribe Now

Already a paid subscriber? Log In

Your go-to for Indy business news.

Try us out for

$1/week

Cancel anytime

Subscribe Now

Already a paid subscriber? Log In

Your go-to for Indy business news.

Try us out for

$1/week

Cancel anytime

Subscribe Now

Already a paid subscriber? Log In

Your go-to for Indy business news.

Try us out for

$1/week

Cancel anytime

Subscribe Now

Already a paid subscriber? Log In